GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported a loss of $12 million in its second quarter.
The Gaithersburg, Maryland-based company said it had a loss of 22 cents per share. Earnings, adjusted for one-time gains and costs, came to 16 cents per share.
The biopharmaceutical company posted revenue of $140.9 million in the period.
For the current quarter ending in September, Emergent Biosolutions said it expects revenue in the range of $180 million to $210 million.
The company expects full-year revenue in the range of $765 million to $835 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
